Brev til redaktøren

• Pulczynski, Elisa Jacobsen; Simonsen, Mikkel Runason; Kuittinen, Outi et al. (2024). Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up. (ekstern lenke)
• Pauly, F.; Fjordén, K.; Leppä, S. et al. (2016). Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study. (ekstern lenke)

Vitenskapelig foredrag

• Wiestad, Helge; Vikmoen, Olav; Ranes, Maria et al. (2024). EFFECTS OF HIGH VS. MODERATE INTENSITY EXERCISE DURING (NEO-)ADJUVANT CHEMOTHERAPY ON CARDIORESPIRA- TORY FITNESS, MITOCHONDRIAL ENZYMES AND CAPILLARIES IN WOMEN WITH BREAST CANCER. (ekstern lenke)
• Wiestad, Tor Helge; Vikmoen, Olav; Ranes, Maria et al. (2023). EFFECTS OF HIGH VS. MODERATE INTENSITY COMBINED STRENGTH AND ENDURANCE TRAINING DURING CHEMOTHERAPY ON CARDIORESPIRATORY FITNESS, MUSCLE STRENGTH AND ENDURANCE IN WOMEN WITH BREAST CANCER. (ekstern lenke)

Vitenskapelig artikkel

• Rekeland, Ingrid Gurvin; Sørland, Kari; Neteland, Lisbeth Lykke et al. (2024). Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. (ekstern lenke)
• Arffman, Maare; Meriranta, Leo; Autio, Matias et al. (2024). Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas. (ekstern lenke)
• Lia, Kjersti; R.K. Jørgensen, Rasmus; Wold, Bente Loftum et al. (2023). Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study. (ekstern lenke)
• Bjorland, Line; Mahesparan, Rupavathana; Fluge, Øystein et al. (2023). Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study. (ekstern lenke)
• Steinsvik, Elisabeth Kjelsvik; Hausken, Trygve; Fluge, Øystein et al. (2023). Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome. (ekstern lenke)
• Isaksen, Kathrine Thuestad; Galleberg, Renate Berget; Mastroianni, Maria Adele et al. (2023). The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy. (ekstern lenke)
• Sandvik, Miriam Kristine; Sørland, Kari; Leirgul, Elisabeth et al. (2023). Endothelial dysfunction in ME/CFS patients. (ekstern lenke)
• Rekeland, Ingrid Gurvin; Sørland, Kari; Bruland, Ove et al. (2022). Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients. (ekstern lenke)
• Hajdarevic, Riad; Lande, Asgeir; Mehlsen, Jesper et al. (2022). Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci. (ekstern lenke)
• Smeland, Knut Bjøro; Holte, Harald; Fagerli, Unn-Merete et al. (2022). Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life. (ekstern lenke)
• Bjorland, Line; Kurz, Kathinka Dæhli; Fluge, Øystein et al. (2022). Butterfly glioblastoma: Clinical characteristics, treatment strategies and outcomes in a population-based cohort. (ekstern lenke)
• Ueland, Marthe; Hajdarevic, Riad; Mella, Olav et al. (2022). No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). (ekstern lenke)
• Bjorland, Line Sagerup; Fluge, Oystein; Gilje, Bjornar et al. (2021). Treatment approach and survival from glioblastoma: Results from a population-based retrospective cohort study from Western Norway. (ekstern lenke)
• Hoel, Fredrik; Hoel, August; Pettersen, Ina Katrine Nitschke et al. (2021). A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. (ekstern lenke)
• Hajdarevic, Riad; Lande, Asgeir; Rekeland, Ingrid Gurvin et al. (2021). Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci. (ekstern lenke)
• Sørland, Kari; Sandvik, Miriam Kristine; Rekeland, Ingrid Gurvin et al. (2021). Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Results From Open-Label Cyclophosphamide Intervention Study. (ekstern lenke)
• Meriranta, Leo; Alkodsi, Amjad; Pasanen, Annika et al. (2021). Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma. (ekstern lenke)
• Lande, Asgeir; Fluge, Øystein; Strand, Elin Bolle et al. (2020). Human Leukocyte Antigen Alleles Associated With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). (ekstern lenke)
• Leppä, Sirpa; Jørgensen, Judit; Tierens, Anne et al. (2020). Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis. (ekstern lenke)
• Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Dahl, Alv A et al. (2020). Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress. (ekstern lenke)
• Fosså, Alexander; Smeland, Knut Bjøro; Fluge, Øystein et al. (2020). Metabolic analysis of amino acids and vitamin B6 pathways in lymphoma survivors with cancer related chronic fatigue. (ekstern lenke)
• Rekeland, Ingrid Gurvin; Fosså, Alexander; Lande, Asgeir et al. (2020). Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study. (ekstern lenke)
• Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Fagerli, Unn-Merete et al. (2019). Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes. (ekstern lenke)
• Fluge, Øystein; Rekeland, Ingrid Gurvin; Lien, Katarina et al. (2019). B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A randomized, double-blind, placebo-controlled trial. (ekstern lenke)
• Simensen, Victoria C; Smeland, Knut Bjøro; Kiserud, Cecilie E. et al. (2019). Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma. (ekstern lenke)
• Giannoccaro, Maria Pia; Cossins, Judith; Sørland, Kari et al. (2019). Searching for Serum Antibodies to Neuronal Proteins in Patients With Myalgic Encephalopathy/Chronic Fatigue Syndrome. (ekstern lenke)
• Pettersen, Ina Katrine Nitschke; Tusubira, Deusdedit; Ashrafi, Hanan et al. (2019). Upregulated PDK4 expression is a sensitive marker of increased fatty acid oxidation. (ekstern lenke)
• Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Dahl, Alv A et al. (2019). Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation. (ekstern lenke)
• Lagerlöf, Ingemar; Holte, Harald; Glimelius, Ingrid et al. (2019). No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy. (ekstern lenke)
• Smeland, Knut Bjøro; Loge, Jon Håvard; Aass, Hans Christian Dalsbotten et al. (2018). Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity. (ekstern lenke)
• Gunther, Oliver P; Gardy, Jennifer L; Stafford, Phillip et al. (2018). Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). (ekstern lenke)
• Rekeland, Ingrid Gurvin; Fluge, Øystein; Alme, Kine et al. (2018). Rituximab serum concentrations and anti-rituximab antibodies during B-cell depletion therapy for myalgic encephalopathy/chronic fatigue syndrome. (ekstern lenke)
• Fluge, Øystein; Mannsåker, Bård; Torp, Anders et al. (2017). Consolidative radiotherapy to residual masses after chemotherapy is associated with improved outcome in diffuse large B-cell lymphoma. A retrospective, population-based study. (ekstern lenke)
• Stensland, Marius; Klos, Jan; Fluge, Øystein et al. (2017). Extranodal NK/T-cell lymphoma, nasal type, primarily involving ovary. (ekstern lenke)
• Lunde, Sigrid; Kristoffersen, Einar Klæboe; Sapkota, Dipak et al. (2016). Serum BAFF and APRIL levels, T-lymphocyte subsets, and immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in myalgic encephalopathy/chronic fatigue syndrome. (ekstern lenke)
• Dale, Jon Espen; Sebjørnsen, Sigrunn; Leh, Sabine Maria et al. (2016). Multimodal therapy is feasible in elderly anal cancer patients. (ekstern lenke)
• Fluge, Øystein; Thurmer, Hanne (2016). Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. (ekstern lenke)
• Fluge, Øystein; Mella, Olav; Bruland, Ove et al. (2016). Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.. (ekstern lenke)
• Kiserud, Cecilie E.; Fagerli, Unn-Merete; Smeland, Knut Bjøro et al. (2016). Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation. (ekstern lenke)
• Loebel, Madlen; Grabowski, Patricia; Heidecke, Harald et al. (2016). Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. (ekstern lenke)
• Smeland, Knut Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum et al. (2016). A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma. (ekstern lenke)
• Fluge, Øystein; Risa, Kristin; Lunde, Sigrid et al. (2015). B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment. (ekstern lenke)
• Pulczynski, Elisa J.; Kuittinen, Outi; Erlanson, Martin et al. (2015). Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group. (ekstern lenke)
• Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum et al. (2015). Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway. (ekstern lenke)
• Taskinen, Minna; Louhimo, Riku; Koivula, Satu et al. (2014). Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma. (ekstern lenke)
• Smeland, Knut Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum et al. (2013). Høydosebehandling med autolog stamcellestøtte ved lymfom i Norge 1987 - 2008. (ekstern lenke)
• Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum et al. (2013). High dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008. (ekstern lenke)
• Holte, Harald; Leppä, Sirpa; Bjørkholm, Mikaela et al. (2013). Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study. (ekstern lenke)
• Knudsen-Baas, Kristin Marie; Moen, Gunnar; Fluge, Øystein et al. (2013). Pseudoprogression in high-grade glioma. (ekstern lenke)
• Myklebust, Mette Pernille; Fluge, Øystein; Immervoll, Heike et al. (2012). Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients. (ekstern lenke)
• Riihijärvi, Sari; Nurmi, Heidi; Holte, Harald et al. (2012). High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy. (ekstern lenke)
• Myklebust, Mette Pernille; Li, Zhiping; Tran, Thai H. et al. (2012). Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. (ekstern lenke)
• Eide, Marianne Brodtkorb; Lauritzsen, Grete Fossum; Kvalheim, Gunnar et al. (2011). High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. (ekstern lenke)
• Myklebust, Mette Pernille; Bruland, Ove; Fluge, Øystein et al. (2011). MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. (ekstern lenke)
• Fluge, Øystein; Bruland, Ove; Risa, Kristin et al. (2011). Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. (ekstern lenke)
• Dresemann, Gregor; Weller, Michael; Rosenthal, Mark A. et al. (2010). Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. (ekstern lenke)
• Dahl, Olav; Fluge, Øystein; Carlsen, Erik et al. (2009). Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. (ekstern lenke)
• Fluge, Øystein; Gravdal, K; Carlsen, E et al. (2009). Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. (ekstern lenke)
• Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove et al. (2009). Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. (ekstern lenke)
• Fluge, Øystein; Mella, Olav (2009). Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series. (ekstern lenke)
• Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove et al. (2008). Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model. (ekstern lenke)
• Bruland, Ove; Fluge, Øystein; Immervoll, Heike et al. (2008). Gene expression reveals two distinct groups of anal carcinomas with clinical implications. (ekstern lenke)
• Dahl, Olav; Borkamo, Erling Dahl; Fluge, Øystein (2008). Current status of antivascular therapy and targeted treatment in the clinic. (ekstern lenke)
• Borkamo, Erling Dahl; Fluge, Øystein; Mella, Olav et al. (2008). Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. (ekstern lenke)
• Fluge, Øystein; Bruland, Ove; Akslen, Lars A. et al. (2006). Gene expression in poorly differentiated papillary thyroid carcinomas. (ekstern lenke)
• Fluge, Øystein; Omenaas, Ernst; Eide, Geir Egil et al. (1998). Fish consumption and respiratory symptoms among young adults in a Norwegian community. (ekstern lenke)
• Svanes, Cecilie; Omenaas, Ernst; Eide, Geir Egil et al. (1998). Hospitalization for lung disease in early childhood and asthma symptoms in young adulthood. (ekstern lenke)

Vitenskapelig oversiktsartikkel/review

• Steiner, Sophie; Fehrer, Annick; Hoheisel, Friederike et al. (2023). Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome – State of the art: Report of the 2nd international meeting at the Charité Fatigue Center. (ekstern lenke)
• Fluge, Øystein; Tronstad, Karl Johan; Mella, Olav (2021). Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). (ekstern lenke)
• Dahl, Olav; Fluge, Øystein (2008). Analkreft. (ekstern lenke)

Leserinnlegg

• Tronstad, Karl Johan; Fluge, Øystein; Mella, Olav (2018). Kronisk utmattelsessyndrom og pyruvat dehydrogenasefunksjon . (ekstern lenke)
• Tronstad, Karl Johan; Fluge, Øystein; Lien, Katarina et al. (2017). Mer om pyruvat dehydrogenase og kronisk utmattelsessyndrom.. (ekstern lenke)
• Tronstad, Karl Johan; Fluge, Øystein; Mella, Olav (2017). Chronic fatigue syndrome and pyruvate dehydrogenase function.. (ekstern lenke)

Vitenskapelig kommentarutgave

• Tronstad, Karl Johan; Fluge, Øystein; Mella, Olav (2018). Kronisk utmattelsessyndrom og pyruvat dehydrogenasefunksjon.. (ekstern lenke)

Faglig kapittel

• Christoffersen, Thoralf; Bruserud, Øystein; Fluge, Øystein et al. (2016). Kreftbiologi og medikamentell terapi. (ekstern lenke)

Sammendrag/abstract

• Leppä, Sirpa; Taskinen, Minna; Koivula, Satu et al. (2012). Use of exon-based transcriptome profiling to identify novel signaling pathways and survival-associated genes in diffuse large B-cell lymphoma. (ekstern lenke)
• Holte, Harald; Bogsrud, Trond; Leppa, S. et al. (2011). (18)FDG PET/CT AFTER INTENSIFIED CHEMO-IMMUNOTHERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), AGED 18-65 YEARS WITH AAIPI 2-3. POSITIVE OR INDETERMINATE LESIONS HAVE A LOW POSITIVE PREDICTIVE VALUE. A NORDIC PHASE II SUBSTUDY. (ekstern lenke)
• Holte, Harald; Leppä, Sirpa; Björkholm, Magnus et al. (2010). R-CHOEP-14 x 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma/Follicular Lymphoma Grade 3 with Age Adjusted IPI Score 2-3: Final Results of a Nordic Lymphoma Group Phase 2 Study Including 156 Patients Aged 18-65 Years. (ekstern lenke)
• Koivula, Satu; Taskinen, Minna; Chen, Ping et al. (2010). Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. (ekstern lenke)
• Riihijärvi, Sari; Nyman, Heidi; Holte, Harald et al. (2010). High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Dose-Dense Chemoimmunotherapy and Systemic CNS Prophylaxis. Results From a Nordic Phase II Study. (ekstern lenke)
• Koivula, Satu; Taskinen, Minna; Chen, Ping et al. (2010). Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. (ekstern lenke)

Vitenskapelig Kapittel/Artikkel/Konferanseartikkel

• Christoffersen, Thoralf; Fluge, Øystein; Lehne, Gustav et al. (2009). Kreftceller og kjemoterapi. (ekstern lenke)
• Lillehaug, Johan; Fluge, Øystein; Varhaug, Jan Erik (2006). Thyroid Cancer: Molecular Biology and Clinical Aspects. (ekstern lenke)

Doktorgradsavhandling

• Fluge, Øystein (2004). Gene expression in papillary thyroid carcinomas, with special reference to tyrosine kinase receptors and growth factors. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin